Ask AI
ProCE Banner Activity

Advancing Pharmacist Excellence in Solid Tumors: Essential Considerations for Expanding From IV to Subcutaneous Immune Checkpoint Inhibitors

Slideset

Download these slides from a recent educational program to determine optimal subcutaneous immunotherapy strategies and improve clinical outcomes for patients with solid tumors.

Released: May 07, 2026

Share

Provided by

Provided by ProCE, LLC.

ProCE Banner

Supporters

Supported by an educational grant from Merck Sharp & Dohme LLC.

Merck Sharp & Dohme LLC

Target Audience

This activity has been designed to meet the educational needs of pharmacists and other healthcare professionals caring for patients with solid tumors.  

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Analyze the pharmacy practice implications of current and emerging data on subcutaneous ICIs for cancer treatment

  • Integrate comprehensive knowledge of SC ICI therapies into pharmacy practice, focusing on preparation and administration technique, safety monitoring and management of drug-related complications, and coordination of complex regimens to optimize patient-centered care

  • Build skills to effectively counsel patients and caregivers on expectations for subcutaneous ICI therapy, including administration, efficacy, and monitoring and management of treatment-related toxicities